Product Code: ETC7674123 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
Publisher: 6Wresearch | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 | |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Italy Geographic Atrophy Market Overview |
3.1 Italy Country Macro Economic Indicators |
3.2 Italy Geographic Atrophy Market Revenues & Volume, 2021 & 2031F |
3.3 Italy Geographic Atrophy Market - Industry Life Cycle |
3.4 Italy Geographic Atrophy Market - Porter's Five Forces |
3.5 Italy Geographic Atrophy Market Revenues & Volume Share, By Age Group, 2021 & 2031F |
3.6 Italy Geographic Atrophy Market Revenues & Volume Share, By Diagnosis, 2021 & 2031F |
3.7 Italy Geographic Atrophy Market Revenues & Volume Share, By Therapeutic Agents Clinical Phase, 2021 & 2031F |
4 Italy Geographic Atrophy Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Aging population: As the population in Italy continues to age, the prevalence of geographic atrophy, which is more common in older individuals, is likely to increase. |
4.2.2 Technological advancements in diagnostics and treatment: Improvements in diagnostic tools and treatment options for geographic atrophy can drive market growth by enhancing early detection and management of the condition. |
4.2.3 Increasing healthcare expenditure: Higher healthcare expenditure in Italy can lead to better access to care for patients with geographic atrophy, potentially boosting market growth. |
4.3 Market Restraints |
4.3.1 Regulatory challenges: Stringent regulations and approval processes for new treatments in Italy can hinder the introduction of innovative therapies for geographic atrophy. |
4.3.2 Limited awareness: Lack of awareness among both healthcare providers and patients about geographic atrophy can result in underdiagnosis and under-treatment of the condition. |
5 Italy Geographic Atrophy Market Trends |
6 Italy Geographic Atrophy Market, By Types |
6.1 Italy Geographic Atrophy Market, By Age Group |
6.1.1 Overview and Analysis |
6.1.2 Italy Geographic Atrophy Market Revenues & Volume, By Age Group, 2021- 2031F |
6.1.3 Italy Geographic Atrophy Market Revenues & Volume, By Above 60 Years, 2021- 2031F |
6.1.4 Italy Geographic Atrophy Market Revenues & Volume, By Above 75 Years, 2021- 2031F |
6.2 Italy Geographic Atrophy Market, By Diagnosis |
6.2.1 Overview and Analysis |
6.2.2 Italy Geographic Atrophy Market Revenues & Volume, By Fundus Autofluorescence (FAF), 2021- 2031F |
6.2.3 Italy Geographic Atrophy Market Revenues & Volume, By Optical Coherence Tomography Angiography (OCT-A), 2021- 2031F |
6.2.4 Italy Geographic Atrophy Market Revenues & Volume, By Multifocal Electroretinography (MfERG), 2021- 2031F |
6.3 Italy Geographic Atrophy Market, By Therapeutic Agents Clinical Phase |
6.3.1 Overview and Analysis |
6.3.2 Italy Geographic Atrophy Market Revenues & Volume, By Late-Stage (Phase III), 2021- 2031F |
6.3.3 Italy Geographic Atrophy Market Revenues & Volume, By Phase II, 2021- 2031F |
6.3.4 Italy Geographic Atrophy Market Revenues & Volume, By Phase I, 2021- 2031F |
7 Italy Geographic Atrophy Market Import-Export Trade Statistics |
7.1 Italy Geographic Atrophy Market Export to Major Countries |
7.2 Italy Geographic Atrophy Market Imports from Major Countries |
8 Italy Geographic Atrophy Market Key Performance Indicators |
8.1 Average age of diagnosis: Monitoring the average age at which patients are diagnosed with geographic atrophy can provide insights into the impact of the aging population on market growth. |
8.2 Adoption rate of new diagnostic technologies: Tracking the rate at which healthcare providers adopt new diagnostic technologies for geographic atrophy can indicate market readiness for innovation. |
8.3 Healthcare expenditure on retinal diseases: Analyzing the proportion of healthcare expenditure allocated to retinal diseases, including geographic atrophy, can help assess the market's growth potential. |
9 Italy Geographic Atrophy Market - Opportunity Assessment |
9.1 Italy Geographic Atrophy Market Opportunity Assessment, By Age Group, 2021 & 2031F |
9.2 Italy Geographic Atrophy Market Opportunity Assessment, By Diagnosis, 2021 & 2031F |
9.3 Italy Geographic Atrophy Market Opportunity Assessment, By Therapeutic Agents Clinical Phase, 2021 & 2031F |
10 Italy Geographic Atrophy Market - Competitive Landscape |
10.1 Italy Geographic Atrophy Market Revenue Share, By Companies, 2024 |
10.2 Italy Geographic Atrophy Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |